Skip to content
Screener

Ionis Pharmaceuticals IONS Prepaid & Other Current

Prepaid & Other Current at other companies

Eli Lilly logo
Eli LillyLLY
$15.37B-14.7%
Arrowhead Research logo
Arrowhead ResearchARWR
$21.72M-8.6%
BioCryst Pharmaceuticals logo
BioCryst PharmaceuticalsBCRX
$14.82M+18.2%
ALN
Alnylam PharmaceuticalsALNY
$302.18M+105%
Stoke Therapeutics, Inc. logo
Stoke Therapeutics, Inc.STOK
$10.12M-20.3%
Intellia Therapeutics logo
Intellia TherapeuticsNTLA
$82.75M+232%

Other financials

Income statement

See full
Revenue$267.9M-40.7%
Gross profit$265.2M-40.8%
Operating income-$102.3M-173%
Net income-$114.6M-193%
EPS (diluted)-$0.69-199%

Balance sheet

See full
Cash & equivalents$350.1M+17.7%
Total debt$262.5M-67.0%
Total equity$439.7M-30.4%
Total assets$3.0B+0.3%

Cash flow

See full
Operating cash flow-$792.8M-426%
CapEx$16.1M+30.7%
Free cash flow-$814.6M-399%

Valuation

See full
Market cap$9.01B+38.9%
Enterprise value$8.92B+27.7%
P/S10.3×+3.4×

Profitability

See full
Gross margin98.2%-0.7pp
Operating margin-68%-234pp
Net margin-64.7%-299pp
FCF margin-77.4%+35.3pp

Returns & leverage

See full
Return on equity-105.5%+336pp
Debt / equity0.6×-0.7×
Current ratio7.9×+5.0×

Where this comes from

Reported directly by Ionis Pharmaceuticals in its filing.

Tagged under the XBRL concept us-gaap:OtherAssetsCurrent.

The source filing: Ionis Pharmaceuticals’s 10-Q, filed July 29, 2026.

Filed
Jul 29, 2026, 5:05 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0000874015-26-000251
Line itemJune 30, 2026December 31, 2025
Short-term investments1,704,5202,305,176
Contracts receivable58,84566,059
Inventories50,83310,048
Other current assets327,011237,092
Total current assets2,491,2742,990,635
Property, plant and equipment, net155,131123,048
Right-of-use assets231,560238,549
Deposits and other assets116,536171,604

ITEM 1. FINANCIAL STATEMENTS

FAQ

What is Ionis Pharmaceuticals's prepaid & other current?
Ionis Pharmaceuticals (IONS) reported prepaid & other current of $327.01M in Q2 2026.
How has Ionis Pharmaceuticals's prepaid & other current changed year-over-year?
Ionis Pharmaceuticals's prepaid & other current increased by 44.6% year-over-year, from $226.11M to $327.01M.
What is the long-term trend for Ionis Pharmaceuticals's prepaid & other current?
Over 5 years (2020 to 2025), Ionis Pharmaceuticals's prepaid & other current has grown at a 11.1% compound annual growth rate (CAGR), from $140.16M to $237.09M.
What does prepaid & other current mean?
Advance payments for expenses (rent, insurance, subscriptions) plus miscellaneous current assets not classified elsewhere.

Ask your AI about Ionis Pharmaceuticals's prepaid & other current.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude